Chunzhen J. Li
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma.
Journal: Frontiers in immunology
Published: May 28, 2025
Comprehensive single-cell and bulk transcriptomic analyses to develop an NK cell-derived gene signature for prognostic assessment and precision medicine in breast cancer.
Journal: Frontiers in immunology
Published: July 06, 2024
A Novel Tumor-Associated Neutrophil-Related Risk Signature Based on Single-Cell and Bulk RNA-Sequencing Analyses Predicts the Prognosis and Immune Landscape of Breast Cancer.
Journal: Journal of Cancer
Published: July 01, 2024
Siglec-G Suppresses CD8+ T Cells Responses through Metabolic Rewiring and Can be Targeted to Enhance Tumor Immunotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 02, 2024
Itaconate facilitates viral infection via alkylating GDI2 and retaining Rab GTPase on the membrane.
Journal: Signal transduction and targeted therapy
Published: March 19, 2024
Progress in relationship between long non-coding RNA and myocardial ischemia-reperfusion injury
Journal: Zhonghua xin xue guan bing za zhi
Published: January 14, 2024
A signature of seven hypoxia-related lncRNAs is a potential biomarker for predicting the prognosis of melanoma.
Journal: American journal of cancer research
Published: January 12, 2024
Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer.
Journal: Frontiers in immunology
Published: October 04, 2023
Risk stratification based on DNA damage-repair-related signature reflects the microenvironmental feature, metabolic status and therapeutic response of breast cancer.
Journal: Frontiers in immunology
Published: December 20, 2022
Last Updated: 09/26/2026